Get the Stockscreener App
2.98
7.58%
0.21
Virax Biolabs Group Ltd stock is traded at $2.98, with a volume of 62,079.
It is up +7.58% in the last 24 hours and down -1.97% over the past month.
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
See More
Previous Close:
$2.77
Open:
$2.81
24h Volume:
62,079
Relative Volume:
0.03
Market Cap:
$2.38M
Revenue:
$12,400
Net Income/Loss:
$-5.03M
P/E Ratio:
-0.1762
EPS:
-16.9112
Net Cash Flow:
$-4.87M
1W Performance:
+13.74%
1M Performance:
-1.97%
6M Performance:
-47.40%
1Y Performance:
-84.91%
1-Day Range:
$2.71
$2.9814
1-Week Range:
$2.5511
$3.10
52-Week Range:
$2.50
$21.75
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
2.98 | 2.47M | 12,400 | -5.03M | -4.87M | -16.91 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
Virax Biolabs Group Ltd (VRAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Virax Biolabs Group Ltd (VRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
VRAX|Virax Biolabs Group Ltd|Price:3.140|Chg%:-0.050 - TradingKey
VRAX|Virax Biolabs Group Ltd|Price:3.050|Chg%:-0.140 - TradingKey
Virax Biolabs Group Ltd (VRAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
VRAX|Virax Biolabs Group Ltd|Price:3.190| - TradingKey
Virax Biolabs Group Ltd (VRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Virax Biolabs Group Ltd (VRAX) Cash Flow - TradingKey
Virax Biolabs Group Ltd (VRAX) Income Statement - TradingKey
TradingKey - TradingKey
Virax Biolabs Company Profile & Introduction - Moomoo
Virax Biolabs (Nasdaq: VRAX) files F-3 to register 1.68M warrant shares - Stock Titan
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
VRAX SEC FilingsVirax Biolabs Group Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
บทสัมภาษณ์ของ Avalon Advanced Materials และ Virax Biolabs เตรียมออกอากาศในรายการ RedChip Small Stocks, Big Money(TM) ทางช่อง Bloomberg TV - Moomoo
Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report - TipRanks
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets - Bitget
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Virax Biolabs reports $6.4m cash, regains Nasdaq compliance By Investing.com - Investing.com Australia
Get insights into the top gainers and losers of Thursday's pre-market session. - ChartMill
Virax Biolabs (NASDAQ: VRAX) boosts cash, secures Fosun deal and regains Nasdaq bid compliance - Stock Titan
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement - Moomoo
Frontier tech research, news & data - MLQ.ai
Virax Biolabs enters immune profiling product supply deal with Fosun - Yahoo Finance
Dow Gains 50 Points; Simulations Plus Earnings Top Views - Benzinga
US Stocks Edge Higher; Delta Air Lines Posts Upbeat Q2 Earnings - Sahm
Virax Biolabs Raises $3.3 Million via Exercise of Investment Options and Issues New Warrants - TipRanks
Virax Biolabs : Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - marketscreener.com
Virax Biolabs (Nasdaq: VRAX) secures $3.3M and issues new equity warrants - Stock Titan
$3.3M cash in, new Virax Biolabs warrants out at $6 a share - Stock Titan
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
The market is filled with gapping stocks in Friday's session. - ChartMill
Top Premarket Decliners - Moomoo
These stocks that are showing activity before the opening bell on Friday. - ChartMill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's after hours session: top gainers and losers - ChartMill
Virax Biolabs Stock Skyrockets 100% on Exclusive Distribution Agreement - Yahoo Finance
Virax Biolabs secures $3.3m from warrant exercise By Investing.com - Investing.com South Africa
Thursday's session: most active stocks - ChartMill
Virax Biolabs locks in $3.3M from option exercise deal - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Virax Biolabs signs supply deal with Fosun Diagnostics By Investing.com - Investing.com India
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 Results - Benzinga
Virax Biolabs Jumps on Fosun Diagnostics Supply Agreement - Quiver Quantitative
Virax Biolabs (VRAX) Stock Explodes 241% on Fosun Diagnostics Partnership - parameter.io
Virax Biolabs (VRAX) Stock Rockets 241% on Fosun Diagnostics Partnership - Blockonomi
Why Did Virax Biolabs Stock Triple In One Session? - Benzinga
Virax Biolabs (VRAX) Stock Surges 241% After Exclusive Southeast Asia Supply Deal - CoinCentral
Forte Biosciences Shares Climb After Positive Phase 1b Vitiligo Trial Results (FBRX) - Yahoo Finance
Trending Stocks Today | Virax Biolabs Soars 259.74% - Moomoo
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):